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Background
Post-Traumatic Stress Disorder (PTSD) Prevalence
ØMarkedly higher in Veteran populations compared to non-Veterans.
Ø Estimated PTSD prevalence rate for Iraqi and Afghanistan Veterans is 23% (Vaughan et al., 2014).
PTSD and Cannabis Use
Ø Many Veterans struggling with PTSD turn to cannabis use for relief, but evidence of its effectiveness is mixed.
Ø Greer et al. (2014) found a reduction of PTSD symptomatology among cannabis-using patients 
Ø Bonn-Miller et al. (2013) found that individuals admitted to a residential program with a current cannabis use disorder 
had lower rates of improvement in PTSD scores.
Purpose of the Present Study
Ø To examine correlates of cannabis use among a large clinical population of Veterans with probable PTSD.
ØWe hypothesized that symptom severity would be lower in cannabis users (cases) compared to non-users (controls), and that 
frequency of cannabis use would be associated with fewer symptoms of PTSD.
References
Bonn-Miller, M.O., Boden, M.T., Vujanovic, A.A., Drescher, K.D., (2013). Psychol. Trauma: Theory, Res., Pract., Policy, 5, 193–200.
Greer, G.R., Grob, C.S., Halberstadt, A.L., (2014). J. Psychoact. Drugs, 46, 73–77.
Vaughan et al., (2014).  Psychiatric Services, 65, 833-835.
Comparison of Cannabis Using (Cases) and Non-Using (Controls) Veterans
Results
Ø PTSD severity did not differ between cannabis-users and non-users (Figure 1).
Ø Cases were more likely to be single, of minority status, less financially stable, and unemployed (Table 1).
Ø Cannabis users had greater levels of comorbidity in alcohol consumption than non-users (Table 1).
Ø Suicidal ideation was significantly more severe in users than in non-users (Table 1).
Ø Differences in depressive symptomatology fell just short of statistical significance (Figure 2).
Method
Ø The study was a matched case-control cross-sectional study using data from January 2011– December 2014 comparing 
cannabis users (n=350) to non-users (n=350) case-matched on age and gender.
Ø Data were used to evaluate the psychiatric and sociocultural associations of cannabis use in Veterans with probable PTSD.
Ø Measures included the PTSD Checklist-Civilian Version (PCL-C), two questions from the Alcohol, Smoking, and Substances 
Involvement Screening Test (ASSIST), the Patient Health Questionnaire for depression (PHQ-9), and the Paykel questionnaire 
for suicidal ideation.
Table 1: Demographic and clinical scores of cannabis-using veterans versus controls
Conclusions and Acknowledgements
Ø Cannabis-using Veterans with probable PTSD did not differ significantly on PTSD symptomatology from non-cannabis users, but had significantly greater suicidal ideation and greater comorbidity of alcohol consumption.
Ø Depressive symptomatology was found to be associated with frequency of cannabis use; those with greater depressive symptomatology were more likely to be daily cannabis users as opposed to non-daily users.
Ø The socio-cultural differences that were found mirror the findings in community based epidemiological data, though the magnitude of difference is greater in this clinical population.
Ø The study results do not preclude a therapeutic effect as cannabis users may have started out being more severe, but were reduced to similar levels of non-users.
Ø The sample is a convenience sample of Veterans being referred for a clinical assessment, and thus may not reflect the population of Veterans not seeking health care in the Veterans Affairs (VA) system.
Ø The prevalence of cannabis use among Veterans with PTSD further highlights the importance and need for scientific research into the potential therapeutic effects of cannabis.
Ø The research presented has been prepared with the support of:
Ø Dean Michael Dryer, College of Science, Health, and Liberal Arts, Philadelphia University
Ø VISN4 Philadelphia VA Medical Center, Mental Illness Research, Education and Clinical Center (MIRECC)
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Figure 2: Mean PHQ-9 scores for DepressionFigure 1: Mean PCL-C scores for PTSD
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Cannabis Cases 
(N=350)
Control Cases Test statistic
(cases vs. controls)
p value
(cases vs. controls)(N=350)
Race (%  Caucasian) 36% 59% Χ2 (1) = 40.01 0.001
Married 32% 51% Χ2 (1) = 26.08 0.001
Employed 23% 40% Χ2 (1) = 21.38 0.001
Financially stable 61% 71% Χ2 (1) = 8.15 0.001
Suicidal ideation 33% 26% Χ2 (1) = 4.17 0.04
Alcohol use (drinks/
week) 6.3 (10.1) 3.1 (7.0) t (349) = 4.65 0.001
